The week in health tech, explained in plain English.Get the free newsletter →
October 4, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Payers

Vertical Integration Is Quietly Inflating Patient Bills

Healthcare's biggest players increasingly own every link in the chain, and patients are paying for it, KFF Health News reports. Hospitals buy physician practices and outpatient facilities. Insurers own pharmacies and pharmacy benefit managers. That consolidation, known as vertical integration, quietly reshapes where care happens and what it costs.

In practice, a patient sent for a routine procedure may be routed to a hospital-owned site that charges far more than an independent clinic for the same service, adding thousands to a bill. Someone filling a prescription may be steered to their insurer's wholly owned pharmacy, which may not stock the prescribed drug or offer the lowest price. The financial incentives favor the integrated company, not the patient.

Because these arrangements are legal and largely invisible on an itemized bill, patients rarely see the markup or the steering. The trend has drawn scrutiny from regulators and lawmakers, but the underlying business model continues to expand across hospitals, insurers, and drug supply chains.

More in Payers

Payers

7 Health System Insurers to Exit Medicare Advantage in 2027

Seven health system-owned insurers are among 11 health plans exiting the individual Medicare Advantage market in 2027, with several others narrowing to special needs plans only.

Why it matters: The exits signal that even provider-owned plans are struggling with Medicare Advantage economics, forcing seniors to find new coverage.

Payers

CMS Projects Lower MA Premiums, Flat Enrollment for 2027

CMS projects lower average Medicare Advantage premiums and flat enrollment of 34 million for 2027, a figure that already trails current membership of 36.1 million.

Why it matters: Medicare Advantage now covers nearly half of all Medicare enrollees, so its premium and growth trajectory shapes revenue for insurers, providers, and the federal budget.

Payers

PBMs Become Rare Bipartisan Target in Washington and States

A bipartisan push in Congress and statehouses aims to rein in pharmacy benefit managers, including proposals to force CVS and rivals to split their PBM and pharmacy businesses.

Why it matters: PBMs sit at the center of US drug pricing, and forced divestiture would upend the business models of the largest healthcare conglomerates.